^
    almost2years
    Study of Anti-PSMA CAR NK Cell (TABP EIC) in Metastatic Castration-Resistant Prostate Cancer (clinicaltrials.gov)
    P1, N=9, Recruiting, Allife Medical Science and Technology Co., Ltd. | Unknown status --> Recruiting | Trial completion date: Dec 2021 --> Jun 2024 | Trial primary completion date: Dec 2020 --> Jun 2023
    Enrollment open • Trial completion date • Trial primary completion date
    |
    NCAM1 (Neural cell adhesion molecule 1)
    |
    FOLH1 expression
    |
    cyclophosphamide • fludarabine IV • ALF501